Results 101 to 110 of about 18,100 (230)

Ceratodermia palmoplantar de Unna-Thost associada a pseudo-ainhum: relato de um caso Unna-Thost type palmoplantar keratoderma associated with pseudoainhum: a case report

open access: yesAnais Brasileiros de Dermatologia, 2004
Os autores relatam um caso de ceratodermia palmoplantar hereditária de Unna-Thost, de apresentação clínica atípica, bem como complicação do tipo estrangulamento ainhumóide no quinto dedo de ambos os pés.
Luciana Valentini de Melo Cesarini   +5 more
doaj   +1 more source

New-Onset Palmar Psoriasis Following mRNA COVID-19 Vaccination: A Case Report

open access: yesInternational Medical Case Reports Journal
Haya Fahad A Alzamami,1 Omer A AlSulaiman,1 Gaeda Khaled I Alkaltham,2 Hadeel K Alotaibi3 1Department of Dermatology, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia; 2Department of Dermatology, Ministry of Health ...
Alzamami HFA   +3 more
doaj  

Palmoplantar hyperkeratotic projections [PDF]

open access: yesJAAD Case Reports, 2020
Wendi Bao, BS   +2 more
openaire   +3 more sources

Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature [PDF]

open access: yes, 2019
Drug-induced subacute cutaneous lupus erythematosus (SCLE) is the most common subtype of drug-induced systemic lupus erythematosus and has been associated with more than 100 drugs.
Marsch, Amanda F, Shakhbazova, Anastasia
core  

Could the IL‐17 cytokine family be a promising target for the treatment of palmoplantar pustulosis?

open access: yes
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 728-729, May 2026.
Ulrich Mrowietz, Sascha Gerdes
wiley   +1 more source

Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study

open access: yesJournal of Dermatological Treatment, 2023
Luciano Ibba   +6 more
doaj   +1 more source

Hereditary epidermolytic palmoplantar keratosis due to a novel desmoglein‐1 mutation: A case report

open access: yesClinical Case Reports
Key Clinical Message Keratosis palmoplantaris striata type I (SPPK‐I) is a rare autosomal‐dominant type of hereditary epidermolytic palmoplantar keratoderma, which can be caused by mutations in desmoglein‐1 (DSG‐1).
Kevin Koschitzki   +8 more
doaj   +1 more source

Safety of guselkumab in hepatitis B virus infection [PDF]

open access: yes, 2019
Reactivation of hepatitis B virus (HBV) following the use of TNF antagonists has been reported and is a contraindication to use of these medications. Although the risk of reactivation of HBV during use of ustekinumab and secukinumab is low in patients ...
Duncan, James Robert   +2 more
core  

Palmoplantar pustulosis [PDF]

open access: yesCanadian Medical Association Journal, 2012
openaire   +2 more sources

Ustekinumab Efficacy in Children with Palmoplantar Psoriasis: Case Series

open access: yesВопросы современной педиатрии
Background. Management with genetically engineered biologic drugs is recommended for patients with palmoplantar psoriasis when standard external therapy, physical therapy, and classical immunosuppressants lack efficacy.
Maria A. Leonova   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy